+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

US Glaucoma Market and Competitive Landscape - 2022

  • PDF Icon


  • August 2022
  • Region: United States
  • Fore Pharma
  • ID: 5644612
The report US Glaucoma Market and Competitive Landscape Highlights - 2022, provides comprehensive insights into Glaucoma pipeline products, Glaucoma epidemiology, Glaucoma market valuations and forecast, Glaucoma drugs sales and competitive landscape in the US.

The research is classified into seven sections - Glaucoma treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope:

  • Glaucoma pipeline: Find out the products in clinical trials for the treatment of Glaucoma by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Glaucoma epidemiology: Find out the number of patients diagnosed (prevalence) with Glaucoma in the US
  • Glaucoma drugs: Identify key products marketed and prescribed for Glaucoma in the US, including trade name, molecule name, and company
  • Glaucoma drugs sales: Find out the sales revenues of Glaucoma drugs in the US
  • Glaucoma market valuations: Find out the market size for Glaucoma drugs in 2021 in the US. Find out how the market advanced from 2019 and forecast to 2027
  • Glaucoma drugs market share: Find out the market shares for key Glaucoma drugs in the US

Benefits of this Research:

The research helps executives to
  • Support monitoring and reporting national Glaucoma market analysis and sales trends
  • Track competitor drugs sales and market share in the US Glaucoma market
  • Track competitive developments in Glaucoma market and present key issues and learnings
  • Synthesize insights for Glaucoma market and products to drive business performance
  • Answer key business questions about the Glaucoma market
  • Evaluate commercial market opportunity assessment, positioning, and segmentation for Glaucoma products
  • Supports decision making in R&D to long term marketing strategies

Table of Contents

1) Glaucoma Treatments
2) Glaucoma Pipeline
3) US Glaucoma Epidemiology
4) Marketed Drugs for Glaucoma in US
5) US Glaucoma Market Size and Forecast
6) US Glaucoma Products Sales and Forecast
7) US Glaucoma Market Competitive Landscape
8) Methodology
9) Contact us

List of Tables
1. Glaucoma Phase 3 Clinical Trials, 2022
2. Glaucoma Phase 2 Clinical Trials, 2022
3. Glaucoma Phase 1 Clinical Trials, 2022
4. Glaucoma Epidemiology, US, 2021 - 2027
5. Marketed Drugs for Glaucoma, US, 2021
6. Glaucoma Market Size and Forecast ($), US, 2019 - 2027
7. Glaucoma Drugs Sales ($), US, 2019 - 2027

List of Figures
1. Glaucoma Epidemiology, US, 2021 - 2027
2. Glaucoma Market Size and Forecast ($), US, 2019 - 2027
3. Glaucoma Drugs Market Share (%), US, 2021